| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | chondrocyte development | 2.85e-05 | 41 | 30 | 3 | GO:0002063 | |
| Domain | LamG | 4.74e-05 | 44 | 30 | 3 | SM00282 | |
| Domain | Laminin_G | 1.09e-04 | 58 | 30 | 3 | IPR001791 | |
| Domain | FA58C | 5.14e-04 | 21 | 30 | 2 | SM00231 | |
| Domain | FA58C_3 | 5.14e-04 | 21 | 30 | 2 | PS50022 | |
| Domain | FA58C_1 | 5.14e-04 | 21 | 30 | 2 | PS01285 | |
| Domain | FA58C_2 | 5.14e-04 | 21 | 30 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 6.73e-04 | 24 | 30 | 2 | PF00754 | |
| Domain | FA58C | 6.73e-04 | 24 | 30 | 2 | IPR000421 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.20e-03 | 32 | 30 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.20e-03 | 32 | 30 | 2 | PS51406 | |
| Domain | Kringle-like | 1.20e-03 | 32 | 30 | 2 | IPR013806 | |
| Domain | FIBRINOGEN_C_1 | 1.20e-03 | 32 | 30 | 2 | PS00514 | |
| Domain | LAM_G_DOMAIN | 1.69e-03 | 38 | 30 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 1.87e-03 | 40 | 30 | 2 | PF02210 | |
| Domain | - | 3.51e-03 | 55 | 30 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 4.87e-03 | 65 | 30 | 2 | IPR009071 | |
| Domain | ConA-like_dom | 5.11e-03 | 219 | 30 | 3 | IPR013320 | |
| Domain | TyrKc | 8.76e-03 | 88 | 30 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 8.76e-03 | 88 | 30 | 2 | IPR020635 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 31150793 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 32203150 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14597763 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 26807827 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30545388 | ||
| Pubmed | IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. | 2.16e-06 | 3 | 30 | 2 | 36949068 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23855785 | ||
| Pubmed | 4.31e-06 | 4 | 30 | 2 | 8995757 | ||
| Pubmed | 5.24e-06 | 529 | 30 | 6 | 14621295 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 23121087 | ||
| Pubmed | Evaluation of genetic susceptibility loci for obesity in Chinese women. | 7.18e-06 | 5 | 30 | 2 | 20616199 | |
| Pubmed | 8.88e-06 | 331 | 30 | 5 | 20634891 | ||
| Pubmed | Evolutionary assembly and disassembly of the mammalian sternum. | 1.08e-05 | 6 | 30 | 2 | 36563692 | |
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.08e-05 | 6 | 30 | 2 | 34143959 | |
| Pubmed | Identification of Epha4 enhancer required for segmental expression and the regulation by Mesp2. | 1.51e-05 | 7 | 30 | 2 | 16728472 | |
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 19176441 | ||
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 37805104 | ||
| Pubmed | CXCL12 is required for stirrup-shaped stapes formation during mammalian middle ear development. | 2.58e-05 | 9 | 30 | 2 | 32319178 | |
| Pubmed | Hoxa5 Activity Across the Lateral Somitic Frontier Regulates Development of the Mouse Sternum. | 2.58e-05 | 9 | 30 | 2 | 35557949 | |
| Pubmed | Tracing colonic embryonic transcriptional profiles and their reactivation upon intestinal damage. | 3.94e-05 | 11 | 30 | 2 | 34348153 | |
| Pubmed | 4.72e-05 | 12 | 30 | 2 | 25889273 | ||
| Pubmed | An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. | 5.58e-05 | 13 | 30 | 2 | 21512138 | |
| Pubmed | 7.50e-05 | 15 | 30 | 2 | 19520072 | ||
| Pubmed | Fat4-Dchs1 signalling controls cell proliferation in developing vertebrae. | 8.57e-05 | 16 | 30 | 2 | 27381226 | |
| Pubmed | MicroRNA-140 plays dual roles in both cartilage development and homeostasis. | 9.70e-05 | 17 | 30 | 2 | 20466812 | |
| Pubmed | 9.70e-05 | 17 | 30 | 2 | 17274974 | ||
| Pubmed | 9.70e-05 | 17 | 30 | 2 | 26389685 | ||
| Pubmed | A comprehensive family-based replication study of schizophrenia genes. | 9.70e-05 | 17 | 30 | 2 | 23894747 | |
| Pubmed | Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development. | 1.35e-04 | 20 | 30 | 2 | 16169709 | |
| Pubmed | 1.35e-04 | 20 | 30 | 2 | 26116666 | ||
| Pubmed | NRG1 signalling regulates the establishment of Sertoli cell stock in the mouse testis. | 1.50e-04 | 21 | 30 | 2 | 30040984 | |
| Pubmed | 1.64e-04 | 22 | 30 | 2 | 15162501 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.64e-04 | 22 | 30 | 2 | 26494785 | |
| Pubmed | Ets1 is required for proper migration and differentiation of the cardiac neural crest. | 1.64e-04 | 22 | 30 | 2 | 20356956 | |
| Pubmed | Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney. | 1.80e-04 | 23 | 30 | 2 | 21035938 | |
| Pubmed | Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation. | 2.31e-04 | 26 | 30 | 2 | 22130515 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.52e-04 | 1061 | 30 | 6 | 33845483 | |
| Pubmed | 2.68e-04 | 28 | 30 | 2 | 31719045 | ||
| Pubmed | 2.88e-04 | 29 | 30 | 2 | 22972626 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 2.88e-04 | 29 | 30 | 2 | 31491374 | |
| Pubmed | JAWS coordinates chondrogenesis and synovial joint positioning. | 2.88e-04 | 29 | 30 | 2 | 18539921 | |
| Pubmed | 3.08e-04 | 30 | 30 | 2 | 21826226 | ||
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 3.74e-04 | 33 | 30 | 2 | 32439762 | |
| Pubmed | β-Catenin regulates endocardial cushion growth by suppressing p21. | 4.20e-04 | 35 | 30 | 2 | 37385754 | |
| Pubmed | 4.45e-04 | 36 | 30 | 2 | 30026494 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.88e-04 | 1201 | 30 | 6 | 35696571 | |
| Pubmed | 4.96e-04 | 38 | 30 | 2 | 32715478 | ||
| Pubmed | 5.23e-04 | 39 | 30 | 2 | 35781329 | ||
| Pubmed | 5.50e-04 | 40 | 30 | 2 | 34677125 | ||
| Pubmed | 5.78e-04 | 41 | 30 | 2 | 30377232 | ||
| Pubmed | Genome-wide association study identifies multiple loci influencing human serum metabolite levels. | 7.27e-04 | 46 | 30 | 2 | 22286219 | |
| Pubmed | 7.27e-04 | 46 | 30 | 2 | 25209997 | ||
| Pubmed | 7.92e-04 | 48 | 30 | 2 | 35905011 | ||
| Cytoband | 1q21 | 1.63e-03 | 91 | 30 | 2 | 1q21 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-07 | 186 | 30 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-07 | 193 | 30 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.04e-07 | 198 | 30 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.12e-06 | 179 | 30 | 4 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.98e-06 | 185 | 30 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 186 | 30 | 4 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-06 | 186 | 30 | 4 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.13e-06 | 186 | 30 | 4 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.28e-06 | 187 | 30 | 4 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.75e-06 | 190 | 30 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.91e-06 | 191 | 30 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.08e-06 | 192 | 30 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-06 | 193 | 30 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.41e-06 | 194 | 30 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.58e-06 | 195 | 30 | 4 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.58e-06 | 195 | 30 | 4 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 8.58e-06 | 195 | 30 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 8.76e-06 | 196 | 30 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 8.76e-06 | 196 | 30 | 4 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 8.94e-06 | 197 | 30 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 8.94e-06 | 197 | 30 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 9.12e-06 | 198 | 30 | 4 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 6.44e-05 | 116 | 30 | 3 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.78e-05 | 118 | 30 | 3 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.78e-05 | 118 | 30 | 3 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.78e-05 | 118 | 30 | 3 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.78e-05 | 118 | 30 | 3 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 6.95e-05 | 119 | 30 | 3 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.83e-05 | 129 | 30 | 3 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 1.13e-04 | 140 | 30 | 3 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 144 | 30 | 3 | 748f4efc59f7afbce6c497524f36d852b8b1d637 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 1.25e-04 | 145 | 30 | 3 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.61e-04 | 158 | 30 | 3 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.89e-04 | 167 | 30 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 169 | 30 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 171 | 30 | 3 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-04 | 172 | 30 | 3 | ddecdb1a0791296929790f78b49008f51a130f8b | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 175 | 30 | 3 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 175 | 30 | 3 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 2.17e-04 | 175 | 30 | 3 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 175 | 30 | 3 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 176 | 30 | 3 | 322259a35f5c97d73ce7f75835dcdb5c954c91f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 176 | 30 | 3 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-04 | 176 | 30 | 3 | e7502a345b2da83a9a60f50cf78f1aef385c99df | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.25e-04 | 177 | 30 | 3 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-04 | 177 | 30 | 3 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 178 | 30 | 3 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 179 | 30 | 3 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 179 | 30 | 3 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.32e-04 | 179 | 30 | 3 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 180 | 30 | 3 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.36e-04 | 180 | 30 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-04 | 181 | 30 | 3 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 182 | 30 | 3 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.44e-04 | 182 | 30 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 182 | 30 | 3 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 182 | 30 | 3 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 182 | 30 | 3 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.48e-04 | 183 | 30 | 3 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 183 | 30 | 3 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 183 | 30 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 184 | 30 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 184 | 30 | 3 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.52e-04 | 184 | 30 | 3 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.56e-04 | 185 | 30 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-04 | 185 | 30 | 3 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 185 | 30 | 3 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 185 | 30 | 3 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-04 | 185 | 30 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-04 | 185 | 30 | 3 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-04 | 185 | 30 | 3 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 185 | 30 | 3 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-04 | 186 | 30 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 186 | 30 | 3 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 5d94e6dd2c92e0c46badeb1e6eb54b69af855a66 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-04 | 186 | 30 | 3 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.60e-04 | 186 | 30 | 3 | 1da52e13096dfe4eb08bd0e7461cb3809b3b3deb | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 187 | 30 | 3 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-04 | 187 | 30 | 3 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 187 | 30 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 187 | 30 | 3 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.64e-04 | 187 | 30 | 3 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| Computational | Genes in the cancer module 200. | 5.43e-04 | 27 | 14 | 2 | MODULE_200 | |
| Computational | Developmental processes. | 7.08e-04 | 333 | 14 | 4 | MODULE_220 | |
| Computational | Genes in the cancer module 80. | 7.64e-04 | 32 | 14 | 2 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 9.68e-04 | 36 | 14 | 2 | MODULE_51 | |
| Computational | RTK signaling. | 1.58e-03 | 46 | 14 | 2 | MODULE_259 | |
| Computational | Genes in the cancer module 85. | 1.94e-03 | 51 | 14 | 2 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 2.41e-03 | 57 | 14 | 2 | MODULE_199 | |
| Computational | ECM and collagens. | 2.78e-03 | 225 | 14 | 3 | MODULE_47 | |
| Computational | Signaling. | 2.96e-03 | 230 | 14 | 3 | MODULE_176 | |
| Computational | Genes in the cancer module 123. | 3.62e-03 | 247 | 14 | 3 | MODULE_123 | |
| Computational | Genes in the cancer module 112. | 4.18e-03 | 260 | 14 | 3 | MODULE_112 | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 5.51e-06 | 197 | 30 | 5 | 6829_UP | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.79e-05 | 8 | 30 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | extracellular matrix protein 1 measurement | 7.74e-05 | 13 | 30 | 2 | EFO_0008126 | |
| Disease | Mammary Carcinoma, Animal | 4.03e-04 | 142 | 30 | 3 | C1257925 | |
| Disease | Animal Mammary Neoplasms | 4.03e-04 | 142 | 30 | 3 | C0024667 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.91e-04 | 152 | 30 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 5.20e-04 | 155 | 30 | 3 | C0024668 | |
| Disease | coronary aneurysm | 5.82e-04 | 35 | 30 | 2 | EFO_1000881 | |
| Disease | Cleft upper lip | 7.23e-04 | 39 | 30 | 2 | C0008924 | |
| Disease | Breast adenocarcinoma | 7.99e-04 | 41 | 30 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 7.99e-04 | 41 | 30 | 2 | C0496956 | |
| Disease | Neuroblastoma | 1.05e-03 | 47 | 30 | 2 | C0027819 | |
| Disease | hypertension (biomarker_via_orthology) | 1.56e-03 | 227 | 30 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | transitional cell carcinoma (is_marker_for) | 1.88e-03 | 63 | 30 | 2 | DOID:2671 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WPQWQGQQPHHRSSS | 726 | P27540 | |
| FVHTVPWDQLFRNPH | 476 | P04626 | |
| QSPTPFNDNQWHHVR | 866 | Q9BZ76 | |
| RWQVQSHHPRSAGQN | 11 | Q7Z408 | |
| DWNPHNDIQAFSRAH | 1121 | Q8TDI0 | |
| VPDQRINHESQWPSH | 1571 | Q8NFD5 | |
| SQARHFWQQDEPPQS | 16 | P02647 | |
| HHQEPLPWAQSTGNQ | 681 | Q9NQX3 | |
| FTEQHPAFPQSPNWH | 81 | P50221 | |
| LQQSHAEPSAPHQAW | 781 | Q5VZ46 | |
| VSFTHWHPFEPNNFR | 461 | Q9UBG0 | |
| WPEQAQRHKTHFQHP | 496 | Q8TCU5 | |
| QHQQQHQPTNWSALP | 451 | Q8IZL2 | |
| PIEPHWHFQQQSHFN | 411 | Q6ZNI0 | |
| HGNPAPNCTWFHNAQ | 336 | Q4KMG0 | |
| NINIFAIHHNPSVWP | 421 | P98187 | |
| DQSHPEPESWNAAQH | 136 | Q16610 | |
| QSPTPFNDNQWHHVR | 866 | Q96NU0 | |
| FQIPWKHATRHSPQQ | 36 | O14896 | |
| HNQQRHGWEFPPHTT | 761 | A6NFQ2 | |
| WQQRQQFRHGSPTAP | 526 | Q6IQ23 | |
| QHQWQQHQQGSAPPT | 661 | P48634 | |
| QTHSPQHWEQPVYTQ | 491 | P48436 | |
| DPHTQREEPFNEHWQ | 246 | Q9NPF2 | |
| GRQCQPWNSQYPHTH | 331 | Q01973 | |
| NENRRHNQWKNSFHP | 1736 | O60673 | |
| NQQHSLHCQWDQPVR | 416 | Q96AE7 | |
| QNQHSYSSPPWAGQH | 86 | Q5H9I0 | |
| FHQWQDNRGSPQPQQ | 46 | Q96JE7 | |
| HQQQPHYASRPGDWH | 66 | Q96JE7 | |
| NIPTHQAQAWRHFTI | 366 | Q8WU66 |